CRBP Corbus Pharmaceuticals Holdings, Inc.
Healthcare$7.91-30.31%ClosedMarket Cap: $99.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.20
P/S
0.00
EV/EBITDA
-1.37
DCF Value
$1.97
FCF Yield
-51.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-70.9%
ROA
-58.5%
ROIC
-70.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-24.3M | $-23.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-22.0M | $-20.6M | $— | — |
| FY null | $0.00 | NaN% | $-85.3M | $-78.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-24.4M | $-23.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-19.2M | $-17.7M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-19.8M | $-17.0M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-12.6M | $-9.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-48.7M | $-40.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-15.5M | $-13.8M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-11.0M | $-10.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-9.6M | $-6.9M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-10.1M | $-8.0M | $-1.81 | — |